Deep Fungal Infections in the Elderly by Kauffman, Carol A. & Terpenning, Margaret S.
SPECIAL REVIEW 
IAGS 36:548-557, 1988 
Deep Fungal Infections in the Elderly 
Carol A. Kaufrnan, MD, and Margaret S. Terpenning, MD 
A s the population ages but continues to be ac- tive and to travel extensively, it is likely that more elderly people will be exposed to and infected with deep fungi endemic in certain 
areas of the country. Travel to the rural Midwest may 
lead to contact with Histoplasma capsulatum, whereas 
exposure to southwestern desert country may result in 
infection with Coccidioides immitis. Leisure activities, 
such as gardening, expose the elderly person to infection 
with Sporothrix schenckii. 
The elderly person is at risk, not only for new infec- 
tion, but also for reactivation of prior infection with 
certain deep fungi. This reactivation may occur years 
after the initial exposure to the organism. For example, 
histoplasmosis in a retiree who was originally from 
Kentucky but who now lives in Arizona may be missed 
unless one remembers to seek evidence for infection 
with organisms found in the original place of residence. 
The natural history of certain fungal infections, such 
as histoplasmosis, is such that manifestations of disease 
are more severe at the extremes of age. Histoplasmosis is 
more likely to present as a disseminated infection in the 
very young and in the elderly, and the mortality from 
this infection is greater at the extremes of age.' On the 
other hand, other fungal infections, such as blastomy- 
cosis, do not appear to show an age-related worsening in 
the severity of illness. The four major deep fungal infec- 
tions endemic in the United States - histoplasmosis, 
blastomycosis, coccidioidomycosis, and sporotrichosis 
-will be reviewed. Those aspects of infection in which 
age appears to play a significant role will be empha- 
sized. 
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HISTOPLASMOSIS 
General Characteristics of Infection Histoplasma cap- 
sulatum is a dimorphic fungus which is endemic to the 
Ohio and Mississippi river valleys and is also common 
in scattered foci in Southeastern and midwestem states.2 
The organism grows to high numbers in environments 
such as caves, deserted buildings, and other areas in 
which birds and bats may congregate and fertilize the 
soil. H. capsulatum is a true pathogen, infecting the nor- 
mal person who inhales the spores of the mycelial form 
of the fungus. Once in the host, the fungus shows its 
dimorphic characteristics and assumes a yeast-like form 
in tissues. 
Although initially causing pulmonary infection, in al- 
most all hosts the organism disseminates widely, albeit 
silently, to cells of the reticuloendothelial system, para- 
sitizing macrophages in spleen, liver, bone marrow, and 
other  organ^.^ In over 994b of patients infected with 
H. capsulatum, cell-mediated immunity develops with 
T-cell sensitization and macrophage activation, result- 
ing in the death of the fungus." In certain hosts, the 
macrophage remains unable to kill the ingested yeast 
and clinical disease results. The two major forms of clin- 
ical disease due to H. capsulatum are pulmonary and 
disseminated infection. In both forms, there is a dispro- 
portionate number of elderly individuals affected, espe- 
cially in the chronic cavitary type of pulmonary infec- 
tion and the progressive type of disseminated infection. 
CHRONIC CAVITARY PULMONARY 
HISTOPLASMOSIS 
Risk of Infection in the Elderly Chronic cavitary pul- 
monary histoplasmosis affects almost entirely middle- 
aged to elderly men who have a history of chronic ob- 
structive pulmonary di~ease.~ In a 20-year study in 
Tennessee, Goodwin et a16 found that 234b of 228 pa- 
tients with chronic cavitary pulmonary histoplasmosis 
were over the age of 60 and 30% were aged 50 to 59 
years.6 Data from the late 1940s through the early 1960s 
showed a similar trend, with the chronic cavitary pul- 
monary form of histoplasmosis clustered almost entirely 
0 1988 by the American Geriatrics Society 0002-861 4/88/$3.50 
IAGS-IUNE 1988-VOL. 36, NO. 6 DEEP FUNGAL INFECTIONS IN THE ELDERLY 549 
in those over the age of 50 and with at least one quarter 
of all the cases in those over the age of 60.7*8 In Wheat's 
study of the massive outbreak of histoplasmosis in Indi- 
anapolis in 1978,9 patients over the age of 60 were 
clearly at risk for the development of cavitary pulmo- 
nary histoplasmosis. Twenty-three of 71 patients over 
the age of 60 (32%) developed cavitary lesions com- 
pared with 23 of 139 patients aged 40 to 59 years (16%) 
and 14 of 358 patients aged 20 to 39 years (4%). The 
combination of chronic obstructive pulmonary disease 
plus age over 60 characterized those at greatest risk of 
cavitation; 70% of patients with these two risk factors 
developed cavitary pulmonary histoplasmosis.9 
Clinical Manifestations Patients with this form of 
histoplasmosis are often mistakenly thought to have 
tuberculosis. The major pulmonary symptoms are 
cough, sputum production, and dyspnea. In addition, 
constitutional symptoms, such as malaise, fatigue, 
weakness, fever, night sweats, and weight loss are com- 
mom6 The chest roentgenogram shows unilateral or bi- 
lateral upper lobe infiltrates with one or more cavities, 
similar to the findings in tuberculosis (Figure 1). 
Diagnosis The diagnosis of chronic cavitary pulmo- 
nary histoplasmosis is usually made with a combination 
of microbiological and serological studies. The organism 
can be cultured from sputum; the yield is increased 
greatly if the microbiology laboratory uses special media 
to eliminate other contaminating fungi, such as Candida 
and Aspergillus.lo H. capsulatum may take as long as 6 
to 8 weeks to grow in culture, but may also appear in 2 
weeks. The usual serologic studies performed are those 
which detect either complement fixing or precipitating 
antibodies to H. capsulatum. Serology can provide pre- 
sumptive evidence for a diagnosis of histoplasmosis be- 
fore the cultures have yielded any growth.6J1 Skin tests 
are not used in the diagnosis of histoplasmosis because 
most persons living in the endemic area will have a 
positive skin test, regardless of whether they have active 
or inactive infection with H. capsulatum. 
Treatment Studies performed after the introduction of 
amphotericin B showed that the chronic cavitary form 
of histoplasmosis was frequently associated with a fatal 
outcome and that treatment with amphotericin B signif- 
icantly reduced the mortality rate.7J2 However, as 
pointed out by Goodwin et al, the overall mortality rate 
remains high even with therapy because of the serious 
underlying chronic obstructive pulmonary disease 
manifested by almost all patients with the chronic cavi- 
tary form of histoplasmosis. Treatment with amphoteri- 
cin B generally requires administration of 25 mg/kg of 
drug over 6 to 8  week^.^,'^ Ketoconazole administration 
is an effective alternative therapy for patients with 
chronic cavitary pulmonary histoplasmosis. The dose 
usually given is 400 mg daily for 6 to 12 months, al- 
though some patients will require 800 mg daily to con- 
trol the infe~ti0n.l~ Relapses can occur after therapy 




Risk of Infection in the Elderly Progressive dissemi- 
nated infection with H. capsulatum is a rare manifesta- 
tion of histoplasmosis, occurring almost entirely at the 
extremes of age. Children less than one year old and the 
elderly are most likely to develop this form of histoplas- 
mosis. In a large series of 84 cases of disseminated histo- 
plasmosis seen over a period of 46 years, Goodwin et a1 
found that 42% of the adults were over the age of 60.' 
This is similar to previous data in which anywhere from 
30% to 50% of adults with progressive disseminated 
histoplasmosis were over the age of 60 years.14J5 In their 
study of the Indianapolis outbreak, Wheat et a1 included 
60 patients with disseminated infection.16 They found 
that age greater than 54 years and immunosuppression 
were the major risk factors for development of dissemi- 
nated infection. 
The reasons for the increased risk of progressive dis- 
ease in elderly individuals are not entirely clear. Most 
FIGURE 1. Chest roentgenogram of a 65-year-old patient with likely, the waning Of cell-mediated which 
chronic cavitary pulmonary histoplasmosis. Extensive bilateral Occurs with aging, plays a role. Whether the defect is 
cavitary disease is present in this man who had severe chronic entirely within the T lymphocyte or whether macro- 
obstructive pulmonary disease. phage dysfunction is important in allowing H. capsula- 
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tum to multiply is not known. The patient with this form 
of histoplasmosis shows continued parasitization of 
macrophages and an inability to kill the ~rganism.',~ In 
some instances it is likely that dissemination is the result 
of reactivation of prior infection in an elderly individ- 
Clinical Manifestations Symptoms manifested by pa- 
tients with progressive disseminated histoplasmosis in- 
clude fever, fatigue, weakness, anorexia, and weight 
loss. Patients may present with a history of non-healing 
mucosal  ulceration^.^-'^*'^ Addison's disease is seen with 
involvement of the adrenal glands, and the initial pre- 
sentation may be that of Addisonian crisis14 (Figure 2). 
The disease may be slowly progressive over a period of 
years or may be subacute with sigruficant disease mani- 
festations occurring within several months of infection. 
Oropharyngeal ulcerations may appear anywhere on 
the buccal mucosa, palate, tongue, or oropharynx. Hep- 
atosplenomegaly is common, whereas lymphadenopa- 
thy and skin lesions occur less Laboratory 
studies will often reveal anemia, leukopenia, and 
thrombocytopenia, as well as an increase in the alkaline 
phosphatase if liver involvement is prominent. The 
chest roentgenogram may show diffuse pulmonary le- 
sions or may appear normal. 
Diagnosis The diagnosis of progressive disseminated 
histoplasmosis is best made by pathologic examination 
of the involved tissues. Bone marrow aspiration and 
biopsy are especially useful; liver or lymph node biopsy 
may also show the organism in macrophages. Intracel- 
lular H. capsulatum may be identified with the use of the 
methenamine silver or Giemsa stainl8 (Figure 3). In ad- 
ua1.17 
FIGURE 3. Bone marrow aspiratefrom a 68-year-old man wi th  
pancytopenia, adrenal insufficiency, and a tongue ulcer. The mac- 
rophage is parasitized wi th  Histoplasma capsdatum. Giemsa 
stain. 
dition to pathologic examination, all biopsy material 
should be submitted for fungal cultures. A positive cul- 
ture provides definitive proof of histoplasmosis, but 
generally takes weeks to grow. Both the complement 
fixation and the precipitin antibody tests are positive in 
most patients with disseminated histoplasmosis, pro- 
viding suggestive evidence for the diagnosis before cul- 
tures have shown the organism." A biopsy should 
always be sought in order to confirm the diagnosis in 
patients with positive serologies. 
Treatment The progressive disseminated form of his- 
toplasmosis is generally fatal unless treated, although in 
some patients the disease may run a protracted course 
for many years before death o c ~ u r s . ~ , ~ J ~  Treatment with 
amphotericin B has been the standard therapy, al- 
though ketoconazole has also been shown to be eff ec- 
tive at a dose of 400 mg or 800 mg daily.13 
BLASTOMYCOSIS 
General Characteristics of Infection Blastomyces der- 
matitidis is a dimorphic fungus found along the Missis- 
sippi River basin from Canada to the Gulf of Mexico and 
throughout the Southeastern United States. Presum- 
ably, the organism's ecological niche is in soil, although 
it has been difficult to grow the organism from soil sam- 
ples, even in areas where outbreaks have occurred.20 
The spores (mycelial phase) are inhaled, causing pul- 
monary infection; the organism assumes the yeast phase 
in tissues. Although Blastomyces may remain localized 
to the lungs, presenting as pneumonitis, the organism 
may spread hematogenously, manifesting as cutaneous 
lesions, osteomyelitis, genitourinary tract infection, or 
is both neutropmc (suppurative) and ganulomatous 
with sensitized lymphocytes and activated macro- 
FIGURE 2. Adrenal gland from a 60-year-old man who died in 
Addisonian crisis seconda y to histoplasmosis. The adrenal is ap- 
there was  extensive replacement of the entire gland wi th  Histo- 
plasma capsulatum. 
proximately five times normal size; on microscopic examination other less common ~resen ta t ions .~~ ,~~  The hostres~onse 
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phages.21 Both phagocytic systems appear to be impor- 
tant in eliminating the organi~m.~~,~ '  
Risk of Infection in the Elderly In contrast to histo- 
plasmosis, in which chronic cavitary pulmonary infec- 
tion and progressive disseminated infection are heavily 
skewed toward those aged over 60 years, there seems to 
be no disproportionate number of cases of blastomy- 
cosis in the elderly population. Most reports from the 
1940s through the 1970s show the major group at risk to 
be 30- to 40-year-old men.21,22*25-27 Many have been 
engaged in outdoor occupations and presumably were 
exposed to Blastornyces in work-related activities.26 
The effect of age as a factor leading to a worse out- 
come in blastomycosis has not been addressed specifi- 
cally in most reports containing large numbers of 
cases.21*22*25,26 It would appear that blastomycosis is dif- 
ferent from histoplasmosis in that there is little evidence 
for increased morbidity as a function of age. For exam- 
ple, careful review of all the case histories listed in Gon- 
yea's review of central nervous systems blastomycosisZ8 
showed no increase of this serious manifestation of 
blastomycosis in those over 60 years of age. The major- 
ity of cases were in those 30 to 40 years of age. On the 
other hand, fatal adult respiratory distress syndrome 
due to blastomycosis has occurred more often than ex- 
pected in elderly patients.29 
Clinical Manifestations The clinical manifestations of 
blastomycosis may be those of pulmonary infection, re- 
flecting the portal of entry, or those of disseminated 
infection, usually with cutaneous, bone, and genitouri- 
nary involvement predominating. Pulmonary infection, 
especially in those involved in an outbreak, may be an 
acute pneumonitis with fever, myalgias and either a dry 
or a productive ~ o u g h . ~ ~ , ~ ~  In contrast, many patients 
present with a clinical picture similar to that seen in 
tuberculosis, with low-grade fever, night sweats, ano- 
rexia, weight loss, and a chronic productive ~ o u g h . ~ ~ , ~ ~  
The chest roentgenogram may show a patchy pneumo- 
nitis, upper lobe cavitary lesions, or bilateral extensive 
infiltrates (Figure 4). 
Cutaneous involvement is quite common, and the le- 
sions are usually distinctive in appearance. They are 
usually slowly enlarging, verrucous, reddish to purplish 
lesions with crusting; microabscesses and granuloma- 
tous components are both present (Figure 5). Some pa- 
tients develop more acute postular or ulcerated lesions. 
The lesions may occur anywhere, but often the face and 
arms are involved. 
Bone and genitourinary tract are the next most com- 
mon organ systems involved.22 The patient may have 
symptoms, such as pain, swelling, and erythema of the 
skin overlying the involved bone. Genitourinary in- 
FIGURE 4. Chest roengenogram of a 72-year-old man wi th  
blastomycosis. Cutaneous and articular involvement was  also 
present. 
Diagnosis Blastomycosis can be diagnosed by direct 
examination of infected body fluids or tissues or by 
growth of B. derrnatitidis in culture. B. derrnatitidis is a 
large thick-walled yeast with a single broad-based bud. 
Cytologic preparations of sputum or bronchial wash- 
ings often are positive (Figure 6), and direct smears or 
KOH preparations of purulent material, synovial fluid, 
sputum, or centrifuged urine may show the organism 
readily. Skin lesions typically show pseudoepithelioma- 
tous hyperplasia on routine hematoxylin and eosin 
V O h ~ ~ e n t  is Often asymptomatic but may present as 
dysuria, hesitancy, pyuria, or epididymal or testicular 
swelling. matitidis. 
FIGURE 5. Typical verrucous lesion of blastomycosis. Biopsy 
revealed broad-based budding yeasts and culture yielded B. der- 
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FIGURE 6. Cytological preparation of washings obtained at the 
time of bronchoscopy in a patient wi th  blastomycosis. Note the 
broad-based single bud attached to the yeast cell. Papanicolaou 
stain. 
stain; organisms are best seen with PAS or methena- 
mine silver stains of tissue. 
B. dermatitidis is generally more easily and more 
quickly grown than H. capsulatum on Sabourauds agar 
or Smith's media. Useful serologic assays for blastomy- 
cosis have lagged behind those for histoplasmosis. 
However, recently ELISA and precipitin tests have ap- 
peared, which show much better specificity and sensi- 
tivity than the complement fixation assay for the diag- 
nosis of blastomycosis.31 
Treatment Amphotericin B is effective therapy for 
blastomycosis, reducing the mortality rate from near 
80% to approximately Although most agree that 
amphotericin B should be given for life-threatening 
blastomycosis, for less severe disease ketoconazole has 
proved to be an effective therapeutic agent, which is less 
toxic than amphotericin B and easier to administer, as it 
is given  rally.'^,^^ Thus, a patient with overwhelming 
pulmonary blastomycosis, central nervous system in- 
volvement, or widespread disseminated infection 
should be treated with 2 grams of amphotericinB, 
whereas patients with cutaneous lesions, osteomyelitis, 
or mild pulmonary infection can be treated quite effec- 
tively with ketoconazole 400 mg daily, increased to 
800 mg daily if no response has ~ccur red . '~ ,~~  
Whether acute pulmonary blastomycosis needs to be 
treated is still debated. Certainly, in some outbreaks, 
patients have cleared their infection without any anti- 
the southwestern United States. The organism is very 
common in the lower Sonoran life zone in Southern 
California, Arizona, and Texas. Like H. capsulatum and 
B. dermatitidis, C. immitis is a true pathogen, causing 
infection in healthy hosts who inhale the highly infec- 
tious  spore^.^' Any activity which stirs up dust in an 
endemic area may lead to an outbreak of coccidioidomy- 
cosis. Isolated cases, as well as epidemics, have been 
reported in association with archeological digs, con- 
struction work, and even activities as simple as driving 
through a contaminated site.35,36 
In its usual form, coccidioidomycosis presents as an 
acute respiratory illness with fever and sometimes joint 
and skin  manifestation^.^^ However, in susceptible pa- 
tients, widespread dissemination occurs and fatal infec- 
tion is possible. The organism is dimorphic, as are 
H. capsulatum and B. dermatitidis, but in the case of 
C. immitis, the tissue form is a large spherule containing 
many en do spore^.^^ The host response to infection is 
both neutrophilic and granulomatous, with cell-me- 
diated immunity necessary for control of infe~tion.~' 
Risk of Infection in the Elderly There is debate about 
whether older persons are more susceptible than 
younger persons to C. immitis. Although Fiese found no 
clear-cut influence of advancing age on dis~emination,~~ 
Sievers found, in a Native American population, that 
the highest mortality from disseminated coccidioidomy- 
cosis was in the very young and in adults over 50 years 
of age.'O Although patients over 50 years old made up 
only 13% of the population, 25% of the patients with 
disseminated disease and 40% of the deaths due to coc- 
cidioidomycosis were in that group. Sievers postulated 
that the older patient may have a higher mortality be- 
cause cell-mediated immunity to C. immitis, as well as 
other intracellular pathogens, decreases with increasing 
age.'O,'l 
Although older persons in endemic areas may have 
reactivation of disease acquired in their youth, an in- 
creasingly large group of elderly persons at risk for de- 
veloping coccidioidomycosis are travelers to the South- 
west from nonendemic areas and elderly persons 
moving into the endemic area when they retire. Thus, it 
is important for physicians in all parts of the United 
States to be cognizant of the disease manifestations of 
coccidiodomycosis, which may appear in an elderly re- 
tiree just returned from wintering in Arizona or south- 
ern California. 
iungal therapy before the diagnosis was e s t a b l i ~ h i d . ~ ~ , ~ ~  
Most of these patients have been children and young 
adults; an elderly person in this situation probably 
should receive ketoconazole therapy. 
COCCIDIOIDOMYCOSIS 
Clinical Manifestations Many patients exposed to 
C. immitis will have a flulike illness with fever, chills, 
cough, headache, and chest pain.35 The respiratory ill- 
ness may be accompanied by erythema nodosum, ery- 
thema multiforme, and arthalgias ("Valley Fever"). Pa- 
tients may also have a line erythematous, macular rash 
with primary coccidioidomycosis.37 
Persons with primary pulmonary coccidioidomycosis 
General Characteristics of Infection Coccidioides im- 
mitis is a fungus endemic to the semiarid desert areas of 
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which does not clear within several weeks time may go 
on to develop persistent pulmonary infection. Chronic 
progressive pneumonia may occur with fever, chest 
pain, productive cough, and progressive downhill 
course.42 Miliary, nodular, and cavitary pulmonary le- 
sions have been described, and in some cases, patients 
can develop rapidly progressive respiratory 
This rapid progression is more common in immunosup- 
pressed hosts, but can occur in persons with apparently 
normal host defenses as well. Pulmonary nodules may 
occur after the primary infection is cleared and are usu- 
ally noted as an incidental finding on the chest roent- 
genogram. Coccidioidal cavities may persist; long-term 
studies by Winn suggest that in most cases these cavities 
are contained by the patient, even when sputum is posi- 
tive for C. immitis.'" Dissemination may occur from late 
cavities, however, and they may be associated with 
hemorrhage, pleural spread, and superinfection. 
Dissemination, the most feared complication of infec- 
tion with C. immitis, occurs more often in certain dark- 
skinned races - blacks, Filipinos, and Native Ameri- 
c a n ~ . ~ ' , ~ ~  Immunosuppressed patients and pregnant 
women also are at risk for disseminated infecti~n.'~,'~ 
Dissemination may occur in any organ of the body, but 
often involves skin, bones, joints, meninges, and genito- 
urinary systems. 
Skin lesions are common in disseminated coccidioido- 
mycosis. The most common is the veruccous granuloma. 
Subcutaneous abscesses may occur anywhere, but on 
the back or hip, they may be mistaken for an incipient 
decubitus ulcer (Figure 7). Osteomyelitis, occurring in 
up to 50% of patients with disseminatedcoccidioidomy- 
cosis, frequently affects areas of tendon insertion, such 
as the malleolus, the tibia1 tubercle, and the patella. The 
genitourinary tract may be extensively involved in coc- 
cidioidal infection. Lesions of the renal parenchyma are 
common at autopsy, and men may have infection of 
prostate, epididymis, spermatic cord, or testicle. Many 
patients have fungi in the urine without dysuria or fre- 
quency." 
Although meningitis is often diagnosed within 
months of the onset of infection, it may remain latent 
and appear years after the initial infection. The clinical 
presentation includes severe headaches, confusion, and 
lethargy; these symptoms may be more common in 
older persons with fungal meningitis.'* 
Diagnosis The diagnosis of coccidioidomycosis usu- 
ally is accomplished by the use of serology, skin testing, 
histopathology, or culture of the organism. As with the 
other deep fungi, the most definitive diagnosis is growth 
of the fungus in culture. However, this is not always 
possible, especially in the case of meningitis; other mo- 
dalities may provide an excellent presumptive diag- 
nosis. 
Tube precipitin, latex agglutination, immunodiffu- 
FIGURE 7.  Subcutaneous abscess next to the knee and overly- 
ing an area of osteomyelitis due to C .  immitis. Smear of the puru- 
lent material from the site showed a large spherule characteristic 
of c. immitis. 
sion and complement fixation tests are available with 
complement fixation being the standard antibody 
assay.34 The delayed hypersensitivity skin test using 
spherulin or coccidioidin as the antigen is a helpful ad- 
junct in diagnosing coccidioidomycosis, in contradis- 
tinction to skin tests for H. capsulatum and B. dermati- 
tidis. 
Although both skin tests and serology are helpful 
diagnostically, finding the organism in tissue and grow- 
ing it in culture are definitive. The distinctive large (80 to 
loop) spherules of C. immitis can be seen in purulent 
material aspirated from draining sinuses, as well as on 
histopathologic examination of tissue sections. C. im- 
mitis is not difficult to grow in vitro. The physician 
should always notify the laboratory, especially in an 
area outside the area endemic for C. immitis, that coccid- 
ioidomycosis is a possible diagnosis so that lab accidents 
with this highly contagious fungus do not occur. 
Treatment Amphotericin B remains the standard ther- 
apy for severe pulmonary and disseminated coccidioi- 
domyc~sis.'~ In general, coccidioidomycosis is more dif- 
ficult to treat than histoplasmosis and blastomycosis. 
When the infection is disseminated, it may be impossi- 
ble to cure. With meningitis, intrathecal therapy is al- 
most always needed, and the prognosis is dismal.50 Ke- 
toconazole has been shown to be effective in treating 
certain forms of coccidiodomycosis and is probably the 
first drug to be used in non - life-threatening infec- 
t ion~.~ '  
SPOROTRICHOSIS 
General Characteristics of Infection Sporothrix 
schenckii is a dimorphic fungus which inhabits the soil in 
many areas of the United States; most cases have been 
reported from the midwestem and eastem half of the 
country. Outbreaks have been described in association 
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with both occupational and leisure ac t iv i t i e~~~ ,~~ ;  sphag- 
num moss, soil, and wood have been contaminated with 
the spores of Spor~thr ix .~~,~ '  The pathogenesis of infec- 
tion differs from the preceding deep fungi in that inha- 
lation of spores is relatively uncommon, whereas direct 
cutaneous and subcutaneous inoculation is the usual 
mode of acquiring the disea~e.5~ 
Once in the host, the fungus assumes the yeast form; 
localized disease, either cutaneous or lymphocutan- 
eous, usually results, but occasionally widespread dis- 
semination occurs. The tissue reaction is usually a mixed 
neutrophilic and granulomatous response, but the spe- 
cifics of the host defense mechanisms important in 
sporothrichosis are not completely kn0wn.5~~~' 
Risk of Infection in the Elderly There does not appear 
to be an increased propensity for sporotrichosis to occur 
in the elderly. The most important factor appears to be 
environmental exposure to the fungus. Not surpris- 
ingly, most of the reported cases have been in men aged 
20 to 40 years who have been exposed to the fungus in 
their occupation. However, with increased participation 
in activities such as gardening, the elderly will be placed 
at greater risk of exposure to S. schenckii and will be 
more likely to acquire sporotrichosis. 
When one reviews cases of extracutaneous sporotri- 
chosis, it appears that extracutaneous spread of infec- 
tion is more likely in older persons. For example, most 
patients with involvement of bones, joints, and tendons 
are over 50 years of age and many are over 60 years 
old.58-60 Disseminated infection has been reported most 
often in men over 45 years of age61,62; in fact, 35% of the 
30 patients with disseminated infection reported by 
Wilson et a1 were men over 60 years of age.62 Thus, there 
appears to be a clustering of cases in the older age-range 
with more serious deep tissue involvement from 
S. schenckii. 
Clinical Manifestations The most common clinical 
manifestation of sporotrichosis is a subcutaneous nod- 
ule or cutaneous ulceration with involvement of the 
lymphatics draining the area. The initial lesion is gener- 
ally at the site of traumatic inoculation of the fungus, 
followed by the development of multiple ulcerated and 
nodular lesions along the lymphatics draining the area. 
The lesions may be painful or painless, they are fre- 
quently purplish or pink in color, and they may drain 
seropurulent fluid (Figure 8). The patient generally is 
afebrile and without systemic symptoms. Progression is 
slow, and the lesions frequently persist for months if 
untreated. 
Extracutaneous focal or disseminated infection is un- 
common,62 In some instances it appears that the orga- 
nism disseminates from the primary site of subcutane- 
ous inoculation. In other instances, it appear likely that 
primary pulmonary infection occurs following inhala- 
tion of the spores of S. schenckii. Isolated articular or 
FIGURE 8. Lyrnphocutaneous sporotrichosis in a farmer's wife, 
who had been scratched by cornstalks at several sites on arms and 
legs. 
bony involvement has been reported. In these instances, 
the illness is generally protracted and frequently mis- 
diagnosed for Pulmonary infection is gener- 
ally chronic with cavitary or nodular lesions, low-grade 
fever, weight loss, and fatigue-not unlike tubercu- 
10sis.~~ 
Disseminated infection occurs only rarely. Most of 
these patients have multiple widespread cutaneous and 
subcutaneous lesions in addition to articular, pulmo- 
nary, genitourinary, and other visceral involvement.62 
Diagnosis S. schenckii grows rather easily after several 
days in culture. Cutaneous and subcutaneous lesions 
should be aspirated or biopsied in order to obtain mate- 
rial for culture. This is the most definitive method for 
diagnosing sporotrichosis. Serology has been less useful 
than in other deep fungal infections. However, recent 
studies suggest that an ELISA and a latex agglutination 
assay may be quite useful in certain invasive forms of 
the disease, such as meningitis, in which it may be very 
difficult to isolate the fungus in culture.M 
Direct examination of purulent material often does 
not reveal the organism, and histopathology may show 
only a mixed pyogenic -granulomatous reaction with- 
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out the fungus being noted. Usually the organism is 
present in rather small numbers; when seen they are 
small cigar-shaped or round yeastlike structures with 
irregular 
Treatment The cutaneous and lymphocutaneous 
forms of sporotrichosis may be treated successfully by 
several methods. The time-honored therapy, a satu- 
rated solution of potassium iodide (SSKI), is still the 
therapy of choice, but side effects are noted in the ma- 
jority of patients receiving the drug for the typical course 
of 3 to 6 months. A recent study showed itraconazole, an 
experimental oral triazole compound, to be quite effec- 
tive in treating localized sporotrichosis and to be free of 
significant side effects.66 Ketoconazole has not been ef- 
fective in treating sporotrich~sis.~~ In certain instances, 
for example, in a pregnant woman with localized sporo- 
trichosis, in whom antifungal agents such as SSKI or 
azoles should not be given, local heat therapy applied to 
the lesions may be effective in eliminating the organism, 
which is heat sensitive, thus curing the infe~tion.~’ 
Disseminated or visceral infections with S. schenckii 
should not be treated with iodides; amphotericin B is the 
treatment of choice in disseminated infection.6z*68 It is 
not known whether the newer azoles will be useful in 
treating disseminated sporotrichosis. 
DISCUSSION 
There is evidence for increased severity of infection in 
elderly patients for all four major deep fungal infections 
occurring in the United States. The correlation between 
increased severity of infection and advancing age is 
strongest for histoplasmosis, in which the chronic cavi- 
tary pulmonary and progressive disseminated forms of 
the disease occur almost entirely in elderly men. Coccid- 
ioidomycosis appears to be a worse infection in elderly 
persons in at least one of the high risk groups, that of 
Native Americans. The rarer manifestations of 
sporotrichosis - disseminated infection and articular 
involvement -occur mostly in older men; however, in 
the case of blastomycosis only minimal data exist sug- 
gesting the disease takes on more serious manifestations 
in the elderly. 
The reasons for the increased severity of infection 
with some of the deep fungi in the elderly have not been 
specifically investigated in humans or in animal models 
of aging. Presumably, decreased cell-mediated immu- 
nity, which occurs in some elderly persons, is related to 
the increased severity of infection in the elderly. This 
would explain infection best in the case of histoplas- 
mosis, in which the data are clear that cell-mediated 
immunity is crucial to resolution of the infection. It is of 
interest that for those infections in which age-related 
severity is not as clear-cut, as with blastomycosis and 
sporotrichosis, cell-mediated immunity alone is proba- 
bly not the sole host defense to eradicate the organism. 
Of importance to the geriatrician is the fact that infec- 
tion with deep fungi can be reactivated later in life. 
Again, the data are most clear for H. capsulatum. Thus, 
when a patient presents with fever, pulmonary infil- 
trates, or evidence of disseminated granulomatous in- 
fection, the history should include prior residence and 
past travel to areas endemic for the deep fungi. Histo- 
plasmosis acquired, for example, while the patient 
served in the armed services in Arkansas or lived in 
Kentucky as a teenager may reactivate years later when 
the patient is a retiree in Arizona, a state in which the 
organism does not occur in the environment. 
Because the deep fungi are acquired from the envi- 
ronment, newly-acquired disease is always possible in 
elderly persons who remain active in leisure activities. 
For example, an elderly gardener might encounter 
S. schenckii while spreading mulch, or an elderly person 
venturing into the desert in southern California might 
be exposed for the first time to C. immitis. Thus, not only 
reactivation infection but also primary infection with 
the deep fungi may occur in elderly persons who en- 
counter a new environment after they move to retire- 
ment communities. It is likely that infection with the 
deep fungi will increase in the years ahead as elderly 













Goodwin RA, Shapiro JL, Thurman GH, et al: Dissemi- 
nated histoplasmosis: Clinical and pathologic correla- 
tions. Medicine 59:1,1980 
Rippon JW: Medical Mycology: The Pathogenic Fungi 
and the Pathogenic Actinomycetes. Philadelphia, WB 
Saunders Co, 1974, p 321 
Schwarz J: Histoplasmosis. New York, Praeger Inc, 1981, 
Taylor ML, Diaz S, Gonzalez PA, et al: Relationship be- 
tween pathogenesis and immune regulation mecha- 
nisms in histoplasmosis: A hypothetical approach. Rev 
Infect Dis 6:775, 1984 
Baum GL, Schwarz J: Chronic pulmonary histoplas- 
mosis. Am J Med 33:873, 1962 
Goodwin RA, Owens FT, Snell JD, et al: Chronic pulmo- 
nary histoplasmosis. Medicine 55:413, 1976 
Furcolow ML: Comparison of treated and untreated se- 
vere histoplasmosis. JAMA 1832323, 1963 
Rubin H, Furcolow ML, Yates JL, et al: The course and 
prognosis of histoplasmosis. Am J Med 27278, 1959 
Wheat LJ, Wass J, Norton J, et al: Cavitary histoplasmosis 
occurring during two large urban outbreaks: Analysis of 
clinical, epidemiologic, roentgenographic, and labora- 
tory features. Medicine 63:201, 1984 
Smith CD, Goodman NL: Improved culture method for 
the isolation of Histoplasma capsulatum and Blastomyces 
dermatitidis from contaminated specimens. Am J Clin 
Path 63:276, 1975 
Wheat LJ, French MLV, Koller RB, et al: The diagnostic 
laboratory tests for histoplasmosis: Analysis of experi- 
P 63 





















ence in a large urban outbreak. Ann Intern Med 97680, 
1982 
Parker JD, Sarosi GA, Doto IL, et al: Treatment of chronic 
pulmonary histoplasmosis. N Engl J Med 283:225,1970 
NIAID Mycoses Study Group: Treatment of blastomy- 
cosis and histoplasmosis with ketoconazole: Results of a 
prospective randomized clinical trial. Ann Intern Med 
103:861, 1985 
Reddy P, Gorelick DF, Brasher CA, et al: Progressive 
disseminated histoplasmosis as seen in adults. Am J Med 
48:629, 1970 
Smith JW, Utz JP: Progressive disseminated histoplas- 
mosis: A prospective study of 26 patients. Ann Intern 
Med 76:557,1972 
Wheat LJ, Slama TG, Norton JA, et al: Risk factors for 
disseminated or fatal histoplasmosis: Analysis of a large 
urban outbreak. Ann Intern Med 96:159, 1982 
Kauffman CA, Israel KS, Smith JW, et al: Histoplasmosis 
in immunosuppressed patients. Am J Med 64:923,1978 
Davies SF, McKenna RW, Sarosi GA, et al: Trephine 
biopsy of the bone marrow in disseminated histoplas- 
mosia. Am J Med 67:617, 1979 
Sarosi GA, Voth DW, Dahe BA, et al: Disseminated his- 
toplasmosis: Results of long-term follow-up. Ann Intern 
Med 75:511,1971 
Tenenbaum MJ, Greenspan J, Kerkering TM: Blastomy- 
cosis. CRC Critical Rev Microbiol 9:139, 1982 
Schwarz J, Baum, GL Blastomycosis. Am J Clin Path 
21:999, 1951 
Witorsch P, Utz JP: North American blastomycosis: A 
study of 40 patients. Medicine 47169,1968 
Drutz DJ, Frey CL Intracellular and extracellular de- 
fenses of human phagocytes against Blastomyces derma- 
titidis conidia and yeasts. J Lab Clin Med 105:737,1985 
Brummer E, Stevens DA. Opposite effects of human 
monocytes, macrophages, and polymorphonuclear neu- 
trophils on replication of Blastomyces dermatitidis in 
vitro. Infect Immun 36:297, 1982 
Duttera MJ, Osterhout S: North American blastomy- 
cosis: A survey of 63 cases. South Med J 62:295, 1969 
Blastomycosis Cooperative Study of the Veterans Ad- 
ministration: Blastomycosis. A review of 198 collected 
cases in Veterans Administration hospitals. Am Rev 
Resp Dis 89:659, 1964 
Sarosi GA, Davies SF Blastomycosis. Am Rev Resp Dis 
120:911, 1979 
Gonyea EF: The spectrum of primary blastomycotic 
meningitis: A review of central nervous system blasto- 
mycosis. Ann Neurol3:26,1978 
Evans ME, Haynes JB, Atkinson JB, et al: Blastomyces 
dermatitidis and the adult respiratory distress syndrome. 
Am Rev Resp Dis 126:1099,1982 
Cockerill FR, Roberts GD, Rosenblatt JE, et al: Epidemic 
of pulmonary blastomycosis (Namekagon Fever) in Wis- 
consin canoeists. Chest 86:688,1984 
Klein BS, Vergeront JM, Kaufman L, et al: Serologic tests 
for blastomycosis: Assessment during a large point 























Bradsher RW, Rice DC, Abernathy RS: Ketoconazole 
therapy for endemic blastomycosis. Ann Intern Med 
103:876, 1985 
Sarosi GA, Hammerman KJ, Tosh FE, et al: Clinical fea- 
tures of acute pulmonary blastomycosis. N Engl J Med 
290:540, 1974 
Drutz DJ, Catanzaro A Coccidioidomycosis, Part I. Am 
Rev Resp Dis 117559,1978 
Werner SB, Pappagianis D, Heindl I, et al: An epidemic 
of coccidioidomycosis among archeology students in 
northern California. N Engl J Med 286:507,1972 
William PL, Sable DC, Mendez P, et al: Symptomatic 
coccidioidomycosis following a severe natural dust 
storm. Chest 76:566, 1979 
Drutz DJ, Cantanzaro A Coccidioidomycosk, Part II. 
Am Rev Resp Dis 117:727,1978 
Rippon JW Medical Mycology: The Pathogenic Fungi 
and the Pathogenic Actinomycetes. Philadelphia, WB 
Saunders Co, 1974, p 356 
Fiese MJ: Coccidioidomycosis. Springfield, IL, Charles C 
Thomas, 1958 
Sievers ML Prognostic factors in disseminated cocadioi- 
domycosis among southwestern American Indians. In 
Ajello L (ed): Coccidioidomycosis: Current clinical and 
diagnostic status. Miami, Symposia Specialists, 1977, p 
63 
Sievers ML Disseminated cocadioidomycosis among 
southwestern American Indians. Am Rev Resp Dis 
109:602, 1974 
Bayer AS: Fungal pneumonias: Pulmonary coccidioidal 
syndromes. Primary and progressive primary coccidioi- 
dal pneumonias. Chest 79:575, 1981 
Bayer AS: Fungal pneumonias: Pulmonary coccidioidal 
syndromes. Miliary, nodular, and cavitary pulmonary 
coccidioidomycosis. Chest 79:686,1981 
Winn WA A long-term study of 300 patients with cavi- 
tary-abscess lesions of the lung of cocadioidal on&. Dis 
Chest 54:268, 1968 
Harris RE: Coccidioidomycosis complicating pregnancy: 
Report of 3 cases and review of the literature. Obstetr 
Gynecol28:401,1966 
Deresinski SC, Stevens DA Coccidioidomycosis in com- 
promised hosts. Medicine 54:377,1975 
Petersen EA, Friedman BA, Crowder ED, et al: Coca- 
dioiduria: Clinical significance. Ann Intern Med 85:34, 
1976 
Stockstill MT, Kauffman CA: Comparison of cryptococ- 
cal and tuberculous meningitis. Arch Neurol40:81,1983 
Drutz DJ: Amphotericin B in the treatment of coccidioi- 
domycosis. Drugs 26:337, 1983 
Winn WA The treatment of coccidioidal meningitis. 
Calif Med 101:78,1964 
Graybd J R  h o l e  antifungal drugs in treatment of coc- 
cidioidomycosis. Sem Respir Infect 1:53, 1986 
Kedes LH, Siemienski J, Braude AI: The syndrome of the 
alcoholic rose gardener. Ann Intern Med 61:1139, 1964 
Schwarz J, Kauffman CA: Occupational hazards from 
deep mycoses. Arch Dermatol 113:1270, 1977 









Powell KE, Taylor E, Phillips BJ, et al: Cutaneous sporo- 
trichosis in forestry workers. Epidemic due to contami- 
nated sphagnum moss. JAMA 240:232, 1978 
Lavalle P, Mariat F Sporotrichosis. Bull Inst Pasteur 
81295, 1983 
Plouffe JF, Silva J, Fekety R, et al: Cell-mediated immune 
responses in sporotrichosis. J Infect Dis 139:152, 1979 
Miyaji M, Nishimura K: Defensive role of granuloma 
against Sporothrix schenckii infection. Mycopathol 
80:117, 1982 
Crout JE, Brewer NS, Tompkins RB: Sporotrichosis ar- 
thritis. Clinical features in seven patients. Ann Intern 
Med 86994,1977 
Levinsky WJ: Sporotrichial arthritis. Arch Intern Med 
129:118, 1972 
Manhart JW, Wilson JA, Korbitz BC: Articular and cuta- 
neous sporotrichosis. JAMA 214:365, 1970 
Lynch PJ, Voorhees JJ, Harrell ER. Systemic sporotri- 








Wilson DE, Mann JJ, Bennett JE, et al: Clinical features of 
extracutaneous sporotrichosis. Medicine 46965,1967 
Pluss JL, Opal SM: Pulmonary sporotrichosis: A review 
of treatment and outcome. Medicine 65:143,1986 
Scott EN, Kaufman L, Brown AC, et al: Serologic studies 
in the diagnosis and management of meningitis due to 
Sporothrix schenckii. N Engl J Med 317:935, 1987 
Bullpitt P, Weedon D: Sporotrichosis: A review of 39 
cases. Pathology 10249, 1978 
Restrepo A, Robledo J, Gomez I, et al: Itraconazole ther- 
apy in lymphangitic and cutaneous sporotrichosis. Arch 
Dermatol 122:413, 1986 
Mackinnon JE, Conti-Diaz IA: The effect of temperature 
on sporotrichosis. Sabouraudia 256, 1962 
Parker JD, Sarosi GA, Tosh FE: Treatment of extracutan- 
eous sporotrichosis. Arch Intern Med 1252358, 1970 
